S

South Florida Research Institute | Lauderdale Lakes, FL

Research site
(Unclaimed)
Location
2951 NW 49th Avenue Suite 101, Lauderdale Lakes, Florida, United States of America
Site insights

Top conditions

Kidney Diseases (11 trials)

Chronic Renal Insufficiency (6 trials)

Diabetic Nephropathies (4 trials)

Hyperphosphatemia (2 trials)

Hereditary Nephritis (2 trials)

Top treatments

Bardoxolone Methyl
Tenapanor
Selonsertib
BI 690517
Iron
INV-202
ADX-629
GS-4997
BI 685509
PF-07321332

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 17
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

This study is open to adults with a type of kidney disease called focal segmental glomerulosclerosis (FSGS). The purpose of this study is to find out...

Enrolling
Kidney Disease, Chronic
Drug: Placebo
Drug: BI 764198

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the t...

Enrolling
Diabetic Kidney Disease
Drug: Placebo
Drug: INV-202

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling
Proteinuric Kidney Disease
Drug: VX-147
Drug: Placebo

The major objective is to demonstrate the safety and efficacy of ANG-3070 in patients with primary glomerular disease and persistent proteinuria.

Enrolling
Proteinuria
Glomerular Disease
Drug: Placebo
Drug: ANG-3070

Trial sponsors

Boehringer Ingelheim logo

Boehringer Ingelheim (3 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems